Company
Novo Nordisk
NYSE:NVO
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
228 stories · page 2 of 3
Nasdaq leads gains as Dow Jones adds more than 1,100 points on 90-day tariff truce
The US and China agreed to slash tariffs on each other’s goods by 115 percentage points—at least for the next 90 days
Novo Nordisk to release clinical update on star drug Wegovy
Results from the SELECT study will be presented at the American Heart Association (AHA) conference on November 11.
Novo Nordisk buys blood pressure treatment to bolster diabetes portfolio
Novo is paying KBP Biosciences US$1.3 billion for ocedurenone